tert-Butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate

Catalog No. :
ACBJNT180
CAS No. :
467454-33-7
Molecular Formula :
C10H17NO2
Molecular Weight :
183.25

IUPAC Name:tert-butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate

tert-Butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$123.00Login to see priceIn stockInquiry
250mg95%$163.00Login to see priceIn stockInquiry
1g95%$407.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate
IUPAC Nametert-butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate
MDL No.MFCD23131242
Molecular FormulaC10H17NO2
Molecular Weight183.25
SMILESO=C(N1C(C2)CC2C1)OC(C)(C)C
InChI KeyXPVHUBNFWUIHDH-UHFFFAOYSA-N
Synonymtert-Butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate;2-Azabicyclo[2.1.1]hexane-2-carboxylic acid, 1,1-dimethylethyl ester;2-Boc-2-azabicyclo[2.1.1]hexane;tert-butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate - [AC80349]
CAS No.467454-33-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBJNT180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUBZ309 route compound structure diagram
    ACEUBZ309871658-02-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBJNT180 route product structure diagram
    ACBJNT180467454-33-7 In Stock
Inquiry

2. ACBJNT180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFVSU672 route compound structure diagram
    ACFVSU67263838-50-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBJNT180 route product structure diagram
    ACBJNT180467454-33-7 In Stock
Inquiry

Comments (0)